Developer docs
API playgroundTry for free, no card

Search company profiles

Wake Research

Full company profile

uuid000b65j

Namestring
Wake Research
Legal namestring
M3 Wake Research
Company typeenum
Private
Founded yearint
2004
Descriptiontext

Wake Research (legally M3 Wake Research) is an integrated, wholly owned clinical research site organization headquartered in Raleigh, North Carolina, and a wholly owned subsidiary of M3, Inc. (TYO: 2413), a publicly traded Japanese clinical research and healthcare technology company. Founded in 1984, the company operates 18+ premier investigational sites across seven U.S. states staffed by 65+ principal investigators and sub-investigators, with access to over 1 million patients through affiliations with multi-specialty group practices, hospitals, and healthcare systems. Its site footprint spans cities including Raleigh, Atlanta, Charleston, Chattanooga, Dallas, Encino, Lake City, Las Vegas, Mission Viejo, San Diego, Tucson, and Wilmington, organized around dedicated general multi-specialty clinics and mental health specialty clinics covering psychiatry, psychedelic-assisted therapy, and TMS.

The company conducts clinical trials on behalf of biopharmaceutical companies, biotechnology firms, medical device manufacturers, pharmaceutical companies, and CROs across 15 therapeutic areas, including Alzheimer's, autoimmune disorders, cardiology, dermatology, diabetes, gastroenterology, hepatology/nephrology, neurology, obesity, oncology/hematology, orthopedics, pulmonology, women's health, and vaccines/prevention. Its service offering covers the full trial lifecycle: patient recruitment and prescreening, protocol-driven trial execution, data collection and verification, and reporting to sponsors. Underlying capabilities include standardized protocols for cross-site data integrity, end-to-end process management from baseline visits through study completion, and a layered recruitment model combining community physician referrals, email referral programs, a website-based trial finder, and active social media outreach. Reported operating metrics include 476 studies completed and 13,000+ participants enrolled in the last five years.

Wake Research generates revenue through B2B professional services contracts with sponsors and CROs on a per-study basis; specific pricing is not publicly disclosed. The company has expanded primarily through acquisitions, including Medical Center for Clinical Research (2017), Women's Health Care Research in San Diego (November 2021), and Multi-specialty Research Associates in Lake City, Florida (May 2022). Go-to-market combines a dedicated business development team for enterprise sponsor relationships with direct-to-patient enrollment at its owned clinics, supported by a network of community research partners across multiple states.

Short descriptiontext

Wake Research is an integrated U.S. clinical research site network operating 18+ wholly owned investigational clinics across seven states, conducting multi-specialty trials for biopharma, biotech, medical device sponsors, and CROs under parent M3, Inc.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersRaleigh, United States
HQ citystring
Raleigh
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices17 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial services, site management organization, clinical research network, patient recruitment services, investigational site network
Industry3 codes
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAGACAC
Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts)
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
NAICS code1 code
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code1 code
  • Services-Health Services8000
Product category
Clinical Research Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Trial Contract Research
TypeProfessional Services
Description

Wake Research generates revenue by conducting clinical trials for pharmaceutical companies, biotechnology firms, medical device companies, and CROs. The company operates as an integrated site organization that provides patient recruitment, trial execution, and data collection services in exchange for contractual fees from sponsors.

wakeresearch.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Wake Research operates as an integrated site organization of premier investigational sites that conducts clinical trials on behalf of biopharmaceutical, biotechnology, medical device, and pharmaceutical companies as well as CROs. The company provides patient recruitment, trial execution, and data collection services across 15 therapeutic areas through a wholly owned network of 18+ clinical research sites across 7 US states.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 476 studies completed in the last five years
+3 more records
Product overview1 text field

M3 Wake Research is a clinical research organization operating as a wholly owned, integrated organization of premier investigational sites that span across North America. The company offers a unified platform combining a network of research clinics, participant recruitment services, and multi-specialty clinical trial conduct across 15 therapeutic areas. Their services include end-to-end clinical trial process management from pre-screening through study completion, working with biopharmaceutical companies, biotechnology firms, medical device companies, pharmaceutical companies, and clinical research organizations (CROs) to advance medical treatments and therapies.

Product and service5 records
1M3 Wake Research Clinical Trial Network
CategoryClinical Research Site Network
Description

An integrated, wholly owned network of premier investigational sites conducting clinical trials for biopharmaceutical, biotechnology, medical device companies, pharmaceutical companies, and CROs across the United States. The network spans 18+ sites across 7 states with 65+ principal investigators.

2Clinical Trial Participant Recruitment
CategoryPatient Recruitment Services
Description

Recruitment, qualification, and retention of volunteers for clinical trials, providing diverse and qualified participant populations across multiple therapeutic areas through the site network and community partnerships.

3Multi-Specialty Clinical Research Services
CategoryTherapeutic Area Clinical Research
Description

Clinical trial conduct across 15 therapeutic areas including Alzheimer's, autoimmune disorders, cardiology, dermatology, diabetes, gastroenterology, hepatology/nephrology, neurology, obesity, oncology/hematology, orthopedics, pulmonology, women's health, and vaccines/prevention.

4Clinical Trial Process Management
CategoryClinical Trial Management Services
Description

End-to-end clinical trial management including pre-screening, screening appointments, baseline visits, follow-up visits, and end-of-study coordination with physicians for sponsors and CROs.

5Site Network Operations for Sponsors and CROs
CategorySite Management Organization (SMO) Services
Description

Integrated, wholly owned and operated site organization providing exceptional efficiency in delivering top-tier clinical trial patient care with affiliations to multi-specialty group practices, hospitals, and healthcare systems for pharmaceutical sponsors and CROs.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership22 partners
1Multi-specialty Research Associates (MSRA)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-05-18
Description

Acquired Multi-specialty Research Associates in Lake City, Florida, expanding Wake Research's network into the state and enhancing multi-specialty expertise. MSRA brings extensive experience in clinical trials including COVID-19 research.

prnewswire.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-11-16
Description

Acquired Women's Health Care Research in San Diego, expanding Wake Research's network to over 18 sites across seven states. The acquisition included Dr. Rovena Reagan who joined as Medical Director specializing in women's health and clinical research.

3Tucson Endocrinology Associates
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Community research partner in Tucson, AZ providing patient referrals for endocrinology-related clinical trials.

wakeresearch.com
4Michelson Psychiatry
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Community research partner in Mission Viejo, CA specializing in psychiatric clinical trials.

wakeresearch.com
5Santee Community Pharmacy
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Community research partner in Santee, CA providing patient referrals for clinical trials.

wakeresearch.com
6RDM Magnolia Practice Care
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Community research partner in Lake City, FL providing patient referrals for clinical trials.

wakeresearch.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Community research partner in Lake City, FL providing internal medicine patient referrals.

8Terrell Family Practice
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Community research partner in Lake City, FL providing family practice patient referrals.

wakeresearch.com
9Synergy Medical Group
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Community research partner in Gainesville, FL providing medical group patient referrals.

wakeresearch.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Community research partner in Sandy Springs, GA specializing in psychiatric clinical trials.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Community research partner in Las Vegas, NV providing mental health patient referrals.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Community research partner in Las Vegas, NV providing weight management patient referrals.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Community research partner in Las Vegas, NV providing medical patient referrals.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Community research partner in Las Vegas, NV providing bariatric patient referrals.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Community research partner in Las Vegas, NV providing volunteer-based medical patient referrals.

16Shaikh Medical Clinic
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Community research partner in Garner, NC providing medical patient referrals.

wakeresearch.com
17Summit Endocrinology & Diabetes
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Community research partner in Cary, NC providing endocrinology and diabetes patient referrals.

wakeresearch.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Community research partner in Cary, NC providing family medicine patient referrals.

19Tidewater Doctors
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Community research partner in West Ashley, SC providing medical patient referrals.

wakeresearch.com
20Compassionate Healthcare
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Community research partner in Hixson, TN providing healthcare patient referrals.

wakeresearch.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Community research partner in Dallas, TX providing diabetes and endocrinology patient referrals.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Community research partner in Dallas, TX providing neurology patient referrals.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Mid-to-large global CRO with strong site-management and clinical operations capabilities. Comparable to Wake Research as a sponsor-facing clinical research services provider, but operates as a full-service CRO with broader geographic and therapeutic reach.

TypeBroad incumbent
Description

Largest global CRO with an integrated site management and patient recruitment offering. Overlaps with Wake Research on the site-network and patient-recruitment functions but operates as a full-service CRO with a much broader portfolio including labs, data, and consulting.

TypeDirect peer
Description

US SMO operating multiple clinical research sites with multi-specialty therapeutic coverage. Directly comparable in business model (owned sites, patient recruitment, sponsor contract research) and customer base (biopharma/CRO sponsors).

TypeDirect peer
Description

US-based integrated clinical research site network formed through the merger of several independent SMOs. Comparable to Wake Research in operating a multi-site, multi-specialty site network targeting biopharma and CRO sponsors.

TypeBroad incumbent
Description

Global biopharma solutions organization combining CRO services with a clinical site network (Syneos Site Solutions). Comparable to Wake Research in site operations and patient recruitment, but offers the full clinical-to-commercial value chain.

TypeBroad incumbent
Description

Global CRO with site management services and partnerships with investigator site networks. Comparable to Wake Research on clinical trial execution and site services, but operates at far larger scale and with a full-service CRO model.

TypeDirect peer
Description

One of the largest US-based integrated site management organizations operating premier investigational sites across multiple therapeutic areas. Directly comparable to Wake Research in site-network model, multi-specialty coverage, and direct-to-sponsor GTM motion.

TypeDirect peer
Description

US-focused integrated SMO network conducting clinical trials across multiple therapeutic areas. Closely comparable to Wake Research in business model (owned sites, multi-specialty), patient recruitment approach, and sponsor customer base.

TypeDirect peer
Description

Mid-sized US SMO network with multi-specialty clinical trial sites. Comparable to Wake Research as a site-management organization competing for biopharma trials with a similar investigator-led, multi-therapeutic model.

TypeDirect peer
Description

Multi-specialty SMO network operating investigational sites across the US for pharmaceutical and biotech sponsors. Comparable to Wake Research as a site-based clinical research organization focused on patient recruitment and trial execution across multiple therapeutic areas.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Wake Research

Clinical Research Serviceswakeresearch.com

Wake Research is an integrated U.S. clinical research site network operating 18+ wholly owned investigational clinics across seven states, conducting multi-specialty trials for biopharma, biotech, medical device sponsors, and CROs under parent M3, Inc.

What Wake Research does

Wake Research (legally M3 Wake Research) is an integrated, wholly owned clinical research site organization headquartered in Raleigh, North Carolina, and a wholly owned subsidiary of M3, Inc. (TYO: 2413), a publicly traded Japanese clinical research and healthcare technology company. Founded in 1984, the company operates 18+ premier investigational sites across seven U.S. states staffed by 65+ principal investigators and sub-investigators, with access to over 1 million patients through affiliations with multi-specialty group practices, hospitals, and healthcare systems. Its site footprint spans cities including Raleigh, Atlanta, Charleston, Chattanooga, Dallas, Encino, Lake City, Las Vegas, Mission Viejo, San Diego, Tucson, and Wilmington, organized around dedicated general multi-specialty clinics and mental health specialty clinics covering psychiatry, psychedelic-assisted therapy, and TMS.

The company conducts clinical trials on behalf of biopharmaceutical companies, biotechnology firms, medical device manufacturers, pharmaceutical companies, and CROs across 15 therapeutic areas, including Alzheimer's, autoimmune disorders, cardiology, dermatology, diabetes, gastroenterology, hepatology/nephrology, neurology, obesity, oncology/hematology, orthopedics, pulmonology, women's health, and vaccines/prevention. Its service offering covers the full trial lifecycle: patient recruitment and prescreening, protocol-driven trial execution, data collection and verification, and reporting to sponsors. Underlying capabilities include standardized protocols for cross-site data integrity, end-to-end process management from baseline visits through study completion, and a layered recruitment model combining community physician referrals, email referral programs, a website-based trial finder, and active social media outreach. Reported operating metrics include 476 studies completed and 13,000+ participants enrolled in the last five years.

Wake Research generates revenue through B2B professional services contracts with sponsors and CROs on a per-study basis; specific pricing is not publicly disclosed. The company has expanded primarily through acquisitions, including Medical Center for Clinical Research (2017), Women's Health Care Research in San Diego (November 2021), and Multi-specialty Research Associates in Lake City, Florida (May 2022). Go-to-market combines a dedicated business development team for enterprise sponsor relationships with direct-to-patient enrollment at its owned clinics, supported by a network of community research partners across multiple states.

Wake Research firmographics

Firmographics
Name
Wake Research
Legal name
M3 Wake Research
Website
https://wakeresearch.com
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
101–250 employees
Short description
Wake Research is an integrated U.S. clinical research site network operating 18+ wholly owned investigational clinics across seven states, conducting multi-specialty trials for biopharma, biotech, medical device sponsors, and CROs under parent M3, Inc.
Ownership category
akta.pro rank

Wake Research industry classification

Industry
Product category
Clinical Research Services
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAGACAC
Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts)
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs

Keywords

  • Clinical trial services
  • Site management organization
  • Clinical research network
  • Patient recruitment services
  • Investigational site network

Where Wake Research is headquartered

Location

Headquarters

HQ city
Raleigh
HQ country
United States
HQ region
North America

Offices17 records

Markets served

Wake Research business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Clinical Trial Contract Research: Wake Research generates revenue by conducting clinical trials for pharmaceutical companies, biotechnology firms, medical device companies, and CROs. The company operates as an integrated site organization that provides patient recruitment, trial execution, and data collection services in exchange for contractual fees from sponsors.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Wake Research product offering

Product offering

Core offering

Wake Research operates as an integrated site organization of premier investigational sites that conducts clinical trials on behalf of biopharmaceutical, biotechnology, medical device, and pharmaceutical companies as well as CROs. The company provides patient recruitment, trial execution, and data collection services across 15 therapeutic areas through a wholly owned network of 18+ clinical research sites across 7 US states.

Product overview

M3 Wake Research is a clinical research organization operating as a wholly owned, integrated organization of premier investigational sites that span across North America. The company offers a unified platform combining a network of research clinics, participant recruitment services, and multi-specialty clinical trial conduct across 15 therapeutic areas. Their services include end-to-end clinical trial process management from pre-screening through study completion, working with biopharmaceutical companies, biotechnology firms, medical device companies, pharmaceutical companies, and clinical research organizations (CROs) to advance medical treatments and therapies.

Differentiator

Problem solved

Functional benefit

Products and services

  • M3 Wake Research Clinical Trial Network An integrated, wholly owned network of premier investigational sites conducting clinical trials for biopharmaceutical, biotechnology, medical device companies, pharmaceutical companies, and CROs across the United States. The network spans 18+ sites across 7 states with 65+ principal investigators.
  • Clinical Trial Participant Recruitment Recruitment, qualification, and retention of volunteers for clinical trials, providing diverse and qualified participant populations across multiple therapeutic areas through the site network and community partnerships.
  • Multi-Specialty Clinical Research Services Clinical trial conduct across 15 therapeutic areas including Alzheimer's, autoimmune disorders, cardiology, dermatology, diabetes, gastroenterology, hepatology/nephrology, neurology, obesity, oncology/hematology, orthopedics, pulmonology, women's health, and vaccines/prevention.
  • Clinical Trial Process Management End-to-end clinical trial management including pre-screening, screening appointments, baseline visits, follow-up visits, and end-of-study coordination with physicians for sponsors and CROs.
  • Site Network Operations for Sponsors and CROs Integrated, wholly owned and operated site organization providing exceptional efficiency in delivering top-tier clinical trial patient care with affiliations to multi-specialty group practices, hospitals, and healthcare systems for pharmaceutical sponsors and CROs.

Quantifiable outcome

  • 476 studies completed in the last five years
  • +3 more outcomes

Companies that use Wake Research

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Wake Research technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Wake Research partnerships and signals

Strategic signal

Partnerships

22 partnerships are on record, tiered core and minor.

  • Multi-specialty Research Associates (MSRA)coreStrategic or Co-development Partner · 18 May 2022Acquired Multi-specialty Research Associates in Lake City, Florida, expanding Wake Research's network into the state and enhancing multi-specialty expertise. MSRA brings extensive experience in clinical trials including COVID-19 research.
  • Women's Health Care ResearchcoreStrategic or Co-development Partner · 16 November 2021Acquired Women's Health Care Research in San Diego, expanding Wake Research's network to over 18 sites across seven states. The acquisition included Dr. Rovena Reagan who joined as Medical Director specializing in women's health and clinical research.
  • Tucson Endocrinology AssociatesminorStrategic or Co-development PartnerCommunity research partner in Tucson, AZ providing patient referrals for endocrinology-related clinical trials.
  • Michelson PsychiatryminorStrategic or Co-development PartnerCommunity research partner in Mission Viejo, CA specializing in psychiatric clinical trials.
  • Santee Community PharmacyminorStrategic or Co-development PartnerCommunity research partner in Santee, CA providing patient referrals for clinical trials.
  • RDM Magnolia Practice CareminorStrategic or Co-development PartnerCommunity research partner in Lake City, FL providing patient referrals for clinical trials.
  • Southern Internal MedicineminorStrategic or Co-development PartnerCommunity research partner in Lake City, FL providing internal medicine patient referrals.
  • Terrell Family PracticeminorStrategic or Co-development PartnerCommunity research partner in Lake City, FL providing family practice patient referrals.
  • Synergy Medical GroupminorStrategic or Co-development PartnerCommunity research partner in Gainesville, FL providing medical group patient referrals.
  • Breakthru Psychiatric SolutionsminorStrategic or Co-development PartnerCommunity research partner in Sandy Springs, GA specializing in psychiatric clinical trials.
  • Nevada Mental HealthminorStrategic or Co-development PartnerCommunity research partner in Las Vegas, NV providing mental health patient referrals.
  • Premier Physicians Weight Loss and WellnessminorStrategic or Co-development PartnerCommunity research partner in Las Vegas, NV providing weight management patient referrals.
  • Safe Harbor MedicalminorStrategic or Co-development PartnerCommunity research partner in Las Vegas, NV providing medical patient referrals.
  • Las Vegas BariatricsminorStrategic or Co-development PartnerCommunity research partner in Las Vegas, NV providing bariatric patient referrals.
  • Volunteers in Medicine of Southern NevadaminorStrategic or Co-development PartnerCommunity research partner in Las Vegas, NV providing volunteer-based medical patient referrals.
  • Shaikh Medical ClinicminorStrategic or Co-development PartnerCommunity research partner in Garner, NC providing medical patient referrals.
  • Summit Endocrinology & DiabetesminorStrategic or Co-development PartnerCommunity research partner in Cary, NC providing endocrinology and diabetes patient referrals.
  • Wake Family MedicineminorStrategic or Co-development PartnerCommunity research partner in Cary, NC providing family medicine patient referrals.
  • Tidewater DoctorsminorStrategic or Co-development PartnerCommunity research partner in West Ashley, SC providing medical patient referrals.
  • Compassionate HealthcareminorStrategic or Co-development PartnerCommunity research partner in Hixson, TN providing healthcare patient referrals.
  • Diabetes and Endocrinology Clinical Consultants of TexasminorStrategic or Co-development PartnerCommunity research partner in Dallas, TX providing diabetes and endocrinology patient referrals.
  • A&B NeurologyminorStrategic or Co-development PartnerCommunity research partner in Dallas, TX providing neurology patient referrals.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Wake Research competitors and assessment

Company assessment

Broad incumbents

  • Medpace: Mid-to-large global CRO with strong site-management and clinical operations capabilities. Comparable to Wake Research as a sponsor-facing clinical research services provider, but operates as a full-service CRO with broader geographic and therapeutic reach.
  • IQVIA: Largest global CRO with an integrated site management and patient recruitment offering. Overlaps with Wake Research on the site-network and patient-recruitment functions but operates as a full-service CRO with a much broader portfolio including labs, data, and consulting.
  • Syneos Health: Global biopharma solutions organization combining CRO services with a clinical site network (Syneos Site Solutions). Comparable to Wake Research in site operations and patient recruitment, but offers the full clinical-to-commercial value chain.
  • ICON plc: Global CRO with site management services and partnerships with investigator site networks. Comparable to Wake Research on clinical trial execution and site services, but operates at far larger scale and with a full-service CRO model.

Direct peers

  • DM Clinical Research: US SMO operating multiple clinical research sites with multi-specialty therapeutic coverage. Directly comparable in business model (owned sites, patient recruitment, sponsor contract research) and customer base (biopharma/CRO sponsors).
  • Flourish Research: US-based integrated clinical research site network formed through the merger of several independent SMOs. Comparable to Wake Research in operating a multi-site, multi-specialty site network targeting biopharma and CRO sponsors.
  • Velocity Clinical Research: One of the largest US-based integrated site management organizations operating premier investigational sites across multiple therapeutic areas. Directly comparable to Wake Research in site-network model, multi-specialty coverage, and direct-to-sponsor GTM motion.
  • Centricity Research: US-focused integrated SMO network conducting clinical trials across multiple therapeutic areas. Closely comparable to Wake Research in business model (owned sites, multi-specialty), patient recruitment approach, and sponsor customer base.
  • Sundance Clinical Research: Mid-sized US SMO network with multi-specialty clinical trial sites. Comparable to Wake Research as a site-management organization competing for biopharma trials with a similar investigator-led, multi-therapeutic model.
  • Alliance for Multispecialty Research (AMR): Multi-specialty SMO network operating investigational sites across the US for pharmaceutical and biotech sponsors. Comparable to Wake Research as a site-based clinical research organization focused on patient recruitment and trial execution across multiple therapeutic areas.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Wake Research social profiles

Digital presence

Wake Research financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Wake Research leadership team

Management profile

Number of profiles

Profiles6 records

Wake Research subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Wake Research funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Wake Research M&A and investment

M&A and investment

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wake Research

What does Wake Research do?

Wake Research operates as an integrated site organization of premier investigational sites that conducts clinical trials on behalf of biopharmaceutical, biotechnology, medical device, and pharmaceutical companies as well as CROs. The company provides patient recruitment, trial execution, and data collection services across 15 therapeutic areas through a wholly owned network of 18+ clinical research sites across 7 US states.

Is Wake Research a public or private company?

Wake Research is a private company. It is classified as corporate owned and is currently operating.

When was Wake Research founded?

Wake Research was founded in 2004. It employs 101 to 250 people.

Where is Wake Research based?

Wake Research is headquartered in Raleigh, United States, in the North America region.

How does Wake Research make money?

One revenue line is on record: clinical Trial Contract Research.

Who are Wake Research's main competitors?

Broad incumbents on record are Medpace, IQVIA, Syneos Health and ICON plc. Direct peers are DM Clinical Research, Flourish Research, Velocity Clinical Research, Centricity Research, Sundance Clinical Research and Alliance for Multispecialty Research (AMR).

Does Wake Research have an API?

No public API is recorded for Wake Research.

What industry is Wake Research in?

Wake Research's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAGACAC, Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts). Its NAICS code is 54171 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
American City Business JournalsFormer Wake Research CEO Ella Grach launches Eximia ResearchElla Grach, former CEO of Wake Research, launched Eximia Research with a capital investment from VSS Capital Partners. The company plans to reach up to 14 sites by year-end, focusing on quality and partnerships with healthcare organizations. Financial terms of the investment were not disclosed.PR NewswireM3 WAKE RESEARCH POISED TO EXPAND PHASE I TRIAL SERVICESM3 Wake Research appointed Lucian Cappoli as Head of Early Development and Phase I Operations to lead and expand Phase I trial services beyond its Raleigh, North Carolina facility. The company's Raleigh site has been conducting Phase I studies since 2012 with 24 beds, and Cappoli plans to leverage his 20 years of experience to grow early phase operations across the network of 23 sites nationwide. M3 Wake Research, a clinical research site network with over 9,100 completed studies, aims to enhance capabilities to include patient populations in addition to healthy volunteers.BioSpaceM3 Wake Research Welcomes New COOM3 Wake Research appointed Lynn King as Chief Operations Officer, effective immediately. King brings over 28 years of clinical operations experience from PPD/Thermo Fisher. The role follows CEO Ella Grach's departure, with Aki Tomaru now acting CEO.PR NewswireWake Research Acquires Women's Health Care ResearchWake Research announced the acquisition of Women's Health Care Research, a San Diego-based clinical trial site led by Dr. Rovena Reagan. This transaction expands Wake Research's national network to five sites in California and adds expertise in women's health indications. The move strengthens Wake Research's integrated network which currently spans 18 sites across seven states.SdbnWake Research Acquires Women’s Health Care Research – San Diego Biotechnology NetworkWake Research announced the acquisition of Women’s Health Care Research, a clinical trial site based in San Diego. This transaction expands Wake Research's national network to include more than 18 sites across seven states. The move aims to increase the reach and expertise of its integrated clinical trial services.PR NewswireWake Research Earns Recognition For Novavax COVID-19 Vaccine Trial, And As Top Clinical Service Provider Of 2021Wake Research, an integrated network of clinical investigative sites, was recognized as a Top Enroller by Novavax in their COVID-19 Phase III vaccine clinical trial, having enrolled over 2,000 patients in the Novavax trial and more than 6,000 patients across multiple COVID vaccine trials including those by Moderna, Pfizer, and Johnson & Johnson. The biotechnology company Novavax reported 89.3% efficacy for its vaccine candidate in U.K. trials, with U.S. trial results still pending and the vaccine awaiting FDA authorization. Wake Research was additionally featured by PharmaTech Outlook as a Top CRO Service Company of 2021 based on its contributions to COVID-19 clinical research efforts.PR NewswireM3 Wake Research Partners With RIP Medical Debt To Help Relieve Americans Of $1 Million Of Medical BillsM3 Wake Research, a national network of clinical investigative sites, partnered with RIP Medical Debt to donate funds that will relieve approximately $1 million of medical debt for Americans in seven states where its research clinics are located. For every patient enrolled in COVID-19 vaccine clinical trials conducted by Wake Research, a donation was made to RIP Medical Debt, which uses $100 donations to abolish approximately $10,000 of medical debt. The company stated the initiative was intended to give back to communities that participated in vital COVID-19 vaccine research during 2020.PR NewswireCOVID-Related Healthcare Services Available At No Cost In Communities NationwideWake Research announced on December 10, 2020, that free COVID-19 healthcare services including testing, vaccines, and investigational treatments are available through its national network of clinical research clinics across nine U.S. cities. The services aim to help individuals with COVID symptoms, those exposed to the virus, and essential workers seeking preventive care, with participants who test positive eligible to earn $100. The company is directing the public to CovidStudies.org and ClinicalTrials.gov to locate services in their communities.PR NewswireEmergeOrtho and Wake Research Partner on Clinical Research for Spine-Related Back PainEmergeOrtho and Wake Research have partnered to form Emerging Medical Research, a clinical research initiative focused on spinal-related back pain conditions in Raleigh, N.C. The partnership will conduct clinical trials investigating lumbar surgery, symptomatic cervical disc disease, artificial cervical disc, and spinal devices. The collaboration aims to advance treatment options for back pain, which affects 10 to 15 percent of adults and is cited as the leading cause of disability worldwide.PR NewswireWake Research Expands North American Presence to West Coast with Acquisition of MCCR - San DiegoWake Research has acquired Medical Center for Clinical Research (MCCR) in San Diego, expanding its clinical research operations to the U.S. West Coast. This transaction increases Wake Research's network to 13 owned or managed sites in the top 20 U.S. metropolitan areas, providing coverage for nearly 13 million people.